Related Experiment Video
Updated: May 4, 2026
08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
7.3K
Increasing value and reducing waste in biomedical research regulation and management
Rustam Al-Shahi Salman1, Elaine Beller2, Jonathan Kagan3
1Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Lancet (London, England)
|January 14, 2014
Summary
Streamlining biomedical research regulation and management can minimize waste. Recommendations focus on proportionate oversight, harmonized processes, efficient study conduct, and integrating research into clinical practice.
Area of Science:
- Biomedical Research
- Health Policy
- Research Management
Background:
- Biomedical research regulation and governance can be burdensome and disproportionate to risks.
- Inefficient management of research processes leads to waste, particularly affecting participant recruitment and retention.
- Current regulatory frameworks may inadvertently compromise patient and public interests.
Purpose of the Study:
- To identify sources of waste in biomedical research regulation, governance, and management.
- To propose recommendations for minimizing waste and improving research efficiency.
- To advocate for a more proportionate and streamlined approach to research oversight.
Main Methods:
- Analysis of existing regulatory and governance frameworks in biomedical research.
- Identification of inefficiencies in research conduct, including participant recruitment, retention, and data management.
- Formulation of recommendations based on expert consensus and best practices.
Main Results:
- Waste in biomedical research stems from regulatory burdens, governance inefficiencies, and procedural management issues.
- Four key recommendations are proposed to reduce waste: regulator influence, streamlined/harmonized regulations, efficient research conduct, and integration into clinical practice.
- Monitoring and publication of adherence metrics are crucial for accountability.
Conclusions:
- Minimizing waste in biomedical research requires a multi-faceted approach involving regulators, policymakers, researchers, and healthcare systems.
- Streamlining regulations and improving research management are essential for efficient and effective biomedical research.
- Integrating research into clinical practice and ensuring proportionate oversight will enhance patient and public benefit.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:22Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
01:56Ethics in Research
23.7K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.7K
01:27Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248